Portfoliotracker

Newron Pharmaceuticals S.p.A.

NWRN.SW · SWISS · Healthcare Biotechnology 0/100 E

8,450 CHF
▼ −0,110 (−1,29 %)
Closed delayed by 15 min
Price as of 17. 11. 17:19, fetched 17. 11. 17:36
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score0 / 100 Market cap175 mil. CHF P/E– Forward P/E15,6 P/S16,8 P/B-16,5 EV/EBITDA-8,1 Dividend yield– FCF yield– EPS-1,35 CHF Net margin-283,6 % Return on equity– Beta0,84 Debt / equity–
52-week range 5,72 to 31,85
3-month average volume0,1 M

We do not have financial statements yet

The company reports in EUR, while the price is quoted in CHF. We do not convert statements between currencies yet, because the multiples (P/E, P/S and others) would come out wrong, so we do not show them here. You can see the price and its history above.

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

Website
newron.com
Employees
27
Country
Italy
Data since
11. 12. 2006

Explore further

Similar companies SANN.SWBSLN.SWKURN.SW

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account